| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | WINSANTOR, INC. | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 7 | NIH | 12/26/2023 | $0 |
| | 2024 | 2020 | WINSANTOR, INC. | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS120354 | Development of a topical fixed-dose combination drug for peripheral neuropathic pain. | 000 | 1 | NIH | 3/28/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS120354 | Development of a topical fixed-dose combination drug for peripheral neuropathic pain. | 000 | 1 | NIH | 1/23/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $889,325 ) |
| | 2022 | 2022 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44CA265565 | Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy | 000 | 2 | NIH | 8/23/2022 | $898,634 |
| | 2022 | 2020 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 002 | 4 | NIH | 1/25/2022 | $0 |
| | 2022 | 2020 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 000 | 4 | NIH | 11/5/2021 | -$17,309 |
| | 2022 | 2020 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 003 | 4 | NIH | 8/10/2022 | -$9,309 |
| | 2022 | 2020 | WINSANTOR INC | 7220 TRADE ST | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 001 | 4 | NIH | 12/13/2021 | $17,309 |
|
| Issue Date FY: 2021 ( Subtotal = $2,086,861 ) |
| | 2021 | 2021 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 001 | 7 | NIH | 3/30/2021 | $985,495 |
| | 2021 | 2021 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44CA265565 | Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy | 000 | 1 | NIH | 9/1/2021 | $1,101,366 |
| | 2021 | 2020 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 6 | NIH | 1/12/2021 | $0 |
| | 2021 | 2020 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 000 | 4 | NIH | 9/13/2021 | $9,309 |
| | 2021 | 2019 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R42CA213555 | Development of Pirenzepine for CIPN | 000 | 3 | NIH | 9/13/2021 | -$9,309 |
| | 2021 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS105177 | Development of Pirenzepine for HIV-SN | 000 | 1 | NIH | 8/20/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,945,073 ) |
| | 2020 | 2020 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1CA213555 | Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN. | 000 | 4 | NIH | 7/15/2020 | $250,000 |
| | 2020 | 2020 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS120354 | Development of a topical fixed-dose combination drug for peripheral neuropathic pain. | 000 | 1 | NIH | 9/23/2020 | $699,491 |
| | 2020 | 2020 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 001 | 6 | NIH | 5/8/2020 | $995,582 |
| | 2020 | 2019 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R42CA213555 | Development of Pirenzepine for CIPN | 000 | 3 | NIH | 7/15/2020 | $0 |
| | 2020 | 2019 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 5 | NIH | 11/25/2019 | $0 |
| | 2020 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS105177 | Development of Pirenzepine for HIV-SN | 000 | 1 | NIH | 2/20/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $2,373,465 ) |
| | 2019 | 2019 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R42CA213555 | Development of Pirenzepine for CIPN | 001 | 3 | NIH | 8/9/2019 | $1,373,465 |
| | 2019 | 2019 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 002 | 5 | NIH | 4/26/2019 | $1,000,000 |
| | 2019 | 2018 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R42CA213555 | Development of Pirenzepine for CIPN | 000 | 2 | NIH | 10/23/2018 | $0 |
| | 2019 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | SB1DK104512 | Assessment of chronic toxicity to support the use of topical pirenzepine for treating diabetic neuropathy | 000 | 4 | NIH | 1/3/2019 | $0 |
| | 2019 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41CA213555 | Development of Pirenzepine for CIPN | 000 | 1 | NIH | 2/5/2019 | $0 |
| | 2019 | 2016 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 001 | 3 | NIH | 12/12/2018 | $0 |
| | 2019 | 2014 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 1 | NIH | 12/12/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $623,955 ) |
| | 2018 | 2018 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R42CA213555 | Development of Pirenzepine for CIPN | 000 | 2 | NIH | 9/20/2018 | $623,955 |
|
| Issue Date FY: 2017 ( Subtotal = $1,735,197 ) |
| | 2017 | 2017 | WINSANTOR, INC. | 6150 LUSK BLVD #B201 | SAN DIEGO | CA | 92121-2737 | SAN DIEGO | USA | SB1DK104512 | Assessment of chronic toxicity to support the use of topical pirenzepine for treating diabetic neuropathy | 000 | 4 | NIH | 4/12/2017 | $970,226 |
| | 2017 | 2017 | WINSANTOR, INC. | 6150 LUSK BLVD #B201 | SAN DIEGO | CA | 92121-2737 | SAN DIEGO | USA | R41CA213555 | Development of Pirenzepine for CIPN | 000 | 1 | NIH | 5/23/2017 | $298,550 |
| | 2017 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS105177 | Development of Pirenzepine for HIV-SN | 000 | 1 | NIH | 9/18/2017 | $496,421 |
| | 2017 | 2017 | WINSANTOR, INC. | 7220 TRADE ST STE 370 | SAN DIEGO | CA | 92121-2380 | SAN DIEGO | USA | R41NS105177 | Development of Pirenzepine for HIV-SN | 001 | 1 | NIH | 9/25/2017 | -$30,000 |
|
| Issue Date FY: 2016 ( Subtotal = $891,725 ) |
| | 2016 | 2016 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 2 | NIH | 4/4/2016 | $300,000 |
| | 2016 | 2016 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 001 | 3 | NIH | 7/1/2016 | $591,725 |
|
| Issue Date FY: 2015 ( Subtotal = $1,088,193 ) |
| | 2015 | 2015 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 001 | 2 | NIH | 6/24/2015 | $986,763 |
| | 2015 | 2014 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 1 | NIH | 11/20/2014 | $101,430 |
| | 2015 | 2014 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 002 | 1 | NIH | 6/24/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $371,908 ) |
| | 2014 | 2014 | WINSANTOR INC | 6150 LUSK BOULEVARD | SAN DIEGO | CA | 92121 | SAN DIEGO | USA | R44DK104512 | Regeneration of Epidermal Nerves in Human Diabetic Neuropathy | 000 | 1 | NIH | 9/23/2014 | $371,908 |
|
|
